J7528 — Mycophenolate mofetil, for suspension, oral, 100 mg
J7528 is a HCPCS Level II code for mycophenolate mofetil, for suspension, oral, 100 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J7528
- Long descriptor
- Mycophenolate mofetil, for suspension, oral, 100 mg
- Short descriptor
- Mycophen mofetil for susp
- Added
- January 1, 2026
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J7528
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7528 is not quite right, the correct code is very often within a few positions of it.
- J7516Injection, cyclosporine, 250 mg
- J7517Mycophenolate mofetil, oral, 250 mg
- J7518Mycophenolic acid, oral, 180 mg
- J7519Injection, mycophenolate mofetil, 10 mg
- J7520Sirolimus, oral, 1 mg
- J7521Tacrolimus, granules, oral suspension, 0.1 mg
- J7525Tacrolimus, parenteral, 5 mg
- J7527Everolimus, oral, 0.25 mg
- J7599Immunosuppressive drug, not otherwise classified
- J7601Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7607Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7608Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
Questions about J7528
What is HCPCS code J7528?
J7528 is a HCPCS Level II code for mycophenolate mofetil, for suspension, oral, 100 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J7528?
The CMS HCPCS file marks J7528 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J7528 paid under the physician fee schedule?
J7528 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).